News from rxi pharmaceuticals corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( OTC-PINK:RXII,OTC-QB:RXII)

Jan 26, 2016, 07:02 ET

RXi Pharmaceuticals to Present at the 18th Annual BIO CEO & Investor Conference

 RXi Pharmaceuticals Corporation (NASDAQ: RXII) a biotechnology company focused on discovering and developing innovative therapies primarily in...

Dec 21, 2015, 07:02 ET

RXi Pharmaceuticals Announces the Initiation of a Phase 2 Trial in Dermatology with Samcyprone for Cutaneous Warts

 RXi Pharmaceuticals Corporation (NASDAQ: RXII) a biotechnology company focused on discovering and developing innovative therapies primarily in...

Dec 14, 2015, 07:02 ET

RXi Pharmaceuticals to Present at the 8th Annual Biotech Showcase 2016

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics primarily in...

Nov 12, 2015, 16:05 ET

RXi Pharmaceuticals Reports Third Quarter 2015 Financial Results and Business Highlights

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics primarily in...

Nov 05, 2015, 07:02 ET

RXi Pharmaceuticals Announces the Initiation of a Phase 1/2 Trial in Ophthalmology with RXI-109 for Retinal Scarring

RXi Pharmaceuticals Corporation (NASDAQ: RXII) a biotechnology company focused on discovering and developing innovative therapies primarily in the...

Oct 29, 2015, 07:02 ET

RXi Pharmaceuticals to Webcast Third Quarter 2015 Financial Results on Thursday, November 12, 2015

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics...

Oct 21, 2015, 07:02 ET

RXi Pharmaceuticals Announces Compound Selection for Cosmetic Product Development with its Novel Self-delivering RNAi Platform

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the...

Oct 20, 2015, 07:02 ET

RXi Pharmaceuticals Announces Remarkable and Positive Results with its Novel Self-Delivering RNAi Platform: Potent Reduction of Long Non-coding RNAs Demonstrated in Collaboration with Biogazelle

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily...

Oct 15, 2015, 07:02 ET

RXi Pharmaceuticals Announces Positive Interim Results in Phase 2a Dermatology Program with RXI-109

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company that owns a broad intellectual property portfolio including a unique...

Oct 12, 2015, 07:02 ET

RXi Pharmaceuticals to Present at Premier Scientific Plastic Surgery Meeting

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily...

Oct 07, 2015, 07:02 ET

RXi Pharmaceuticals to Present at 14th Annual BIO Investor Forum

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the...

Oct 05, 2015, 07:02 ET

RXi Pharmaceuticals Bolsters Protection for its Novel Self-Delivering RNAi Platform with Notice of Allowance from USPTO

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the...

Sep 29, 2015, 07:02 ET

RXi Pharmaceuticals to Present at Dawson James Securities Growth Stock Conference

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily...

Sep 28, 2015, 07:02 ET

RXi Pharmaceuticals Granted Patent in China for Lead Clinical Candidate RXI-109

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the...

Sep 15, 2015, 07:02 ET

RXi Pharmaceuticals to Present at the 15th Annual Biotech in Europe Forum for Global Partnering and Investment Conference

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily...

Sep 08, 2015, 07:02 ET

RXi Pharmaceuticals Strengthens Intellectual Property Portfolio for Ocular Indications

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily...

Aug 31, 2015, 07:02 ET

RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily...

Aug 12, 2015, 07:02 ET

RXi Pharmaceuticals Reports Second Quarter 2015 Financial Results and Business Highlights

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics...

Jul 29, 2015, 07:02 ET

RXi Pharmaceuticals to Webcast Second Quarter 2015 Financial Results on Wednesday, August 12, 2015

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics...

Jun 09, 2015, 07:02 ET

RXi Pharmaceuticals Strengthens Intellectual Property Portfolio for Novel RNAi Platform

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics,...